Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib
Article in Gastroenterology Research (February 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy.
Article in Hepatology (September 2023)
Development and validation of prognostic risk prediction models for hepatocellular carcinoma patients treated with immune checkpoint inhibitors based on a systematic review and meta-analysis of 47 cohorts
Article in Frontiers in Immunology (July 2023)